The Week in Review: May 5, 2017 – May 12, 2017

Friday, May 12, 2017 News Recap HCV on the Rise in Boomers, Women and Children A new report from the CDC in the USA has found that HCV is concentrated among baby boomers and is increasing rapidly among new generations of Americans.  In over just five years, the number of new hepatitis C virus infections reported to the CDC has nearly tripled, reaching a 15-year high. New hepatitis C virus infections are increasing most rapidly among young people, wi...

Exploring Treatment Failure Among Hepatitis C Patients

Although direct acting antivirals (DAAs) have revolutionized the treatment of hepatitis C virus (HCV), a small fraction of patients still experience treatment failure. In an editorial in a special issue of the journal Viruses, Che Colpitts, PhD, and Thomas Baumert, MD, of the Institute of Research of Viral Maladies in Strasbourg, France, describe why the research included is important to the future of treating HCV. “In the USA, chronic hepatitis C infecti

Quest Launches New Hepatitis C Virus Test Capabilities for Recently FDA-approved Antiviral Therapies

Apr 14, 2016 MADISON, N.J., April 14, 2016 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has expanded its chronic hepatitis C virus (HCV) test services to include new capabilities to help physicians identify or predict resistance to several HCV therapies, including the recently FDA-approved Zepatier™, from Merck, and Daklinza™, from Bristol-Myers Squibb. T...